AEMD
Aethlon Medical Inc
NASDAQ: AEMD · HEALTHCARE · MEDICAL DEVICES
$2.19
-10.33% today
Updated 2026-06-05
Market cap
$3.78M
P/E ratio
—
P/S ratio
2.37x
EPS (TTM)
$-48.46
Dividend yield
—
52W range
$1 – $30
Volume
0.7M
WallStSmart proprietary scores
39
out of 100
Grade: D
Sell
Investment rating
6.3
Growth
B7.3
Quality
B+3.0
Profitability
D4.0
Valuation
C3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$4.75
+116.89%
12-Month target
—
—
Intrinsic (DCF)
$1.32
Margin of safety
-58.33%
Price chart
Stock snapshot
Strengths
+ Revenue growth 4,278.00% QoQ
+ Debt/equity 0.07x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-7.00T
- 58.33% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $574245.00 | $0.00 | $0.00 | — | $574240.00 |
| Net income | $-12.03M | $-12.21M | $-13.39M | $-7.15T | $-7.15T |
| EPS | — | — | — | — | $-48.46 |
| Free cash flow | $-11.45M | $-10.38M | $-7.65M | $-7.00T | $-7.00T |
| Profit margin | -2,094.89% | — | — | — | — |
Peer comparison
Smart narrative
Aethlon Medical Inc trades at $2.19. Our Smart Value Score of 39/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $574240.00. Our DCF model estimates intrinsic value at $1.32.
Frequently asked questions
What is Aethlon Medical Inc's stock price?
Aethlon Medical Inc (AEMD) trades at $2.19, on a P/S of 2.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Aethlon Medical Inc overvalued?
Aethlon Medical Inc carries a Smart Value Score of 39/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $1.32 against the $2.19 price, so on cash flow terms the market is paying a premium for Aethlon Medical Inc's growth. The Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Aethlon Medical Inc (AEMD)?
The 12-month analyst consensus target is $4.75, about 116.9% above the current $2.19. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Aethlon Medical Inc (AEMD)?
Our DCF model estimates intrinsic value at $1.32, a -58.3% margin of safety versus today's $2.19. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Aethlon Medical Inc's revenue?
Aethlon Medical Inc's trailing twelve-month revenue is $574240.00. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.37x
ROE-171.64%
Beta1.50
50D MA$2.25
200D MA$4.41
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—